Chris Shibutani

Stock Analyst at Goldman Sachs

(2.73)
# 2,084
Out of 5,044 analysts
96
Total ratings
54%
Success rate
4.09%
Average return

Stocks Rated by Chris Shibutani

Vaxcyte
Apr 1, 2025
Maintains: Buy
Price Target: $138$100
Current: $44.57
Upside: +124.37%
Erasca
Mar 21, 2025
Maintains: Buy
Price Target: $3.5$3
Current: $2.44
Upside: +22.95%
Seres Therapeutics
Mar 14, 2025
Maintains: Sell
Price Target: $20$15
Current: $17.16
Upside: -12.59%
Alkermes
Feb 14, 2025
Maintains: Buy
Price Target: $30$32
Current: $31.00
Upside: +3.23%
BioNTech SE
Nov 8, 2024
Upgrades: Buy
Price Target: $90$137
Current: $105.03
Upside: +30.44%
Syndax Pharmaceuticals
Nov 7, 2024
Maintains: Buy
Price Target: $30$33
Current: $13.51
Upside: +144.26%
United Therapeutics
Nov 1, 2024
Maintains: Neutral
Price Target: $243$302
Current: $415.34
Upside: -27.29%
Royalty Pharma
Aug 14, 2024
Maintains: Buy
Price Target: $50$51
Current: $36.41
Upside: +40.07%
Johnson & Johnson
Jul 19, 2024
Maintains: Neutral
Price Target: $160$155
Current: $186.93
Upside: -17.08%
Amylyx Pharmaceuticals
Jul 12, 2024
Maintains: Neutral
Price Target: $3$4
Current: $14.32
Upside: -72.07%
Maintains: Neutral
Price Target: $18$20
Current: $6.66
Upside: +200.30%
Maintains: Neutral
Price Target: $650$723
Current: $820.10
Upside: -11.84%
Maintains: Neutral
Price Target: $29$26
Current: $21.77
Upside: +19.43%
Maintains: Buy
Price Target: $134$153
Current: $147.38
Upside: +3.81%
Upgrades: Buy
Price Target: $173
Current: $227.54
Upside: -23.97%
Upgrades: Outperform
Price Target: n/a
Current: $60.92
Upside: -
Maintains: Buy
Price Target: $81$69
Current: $42.82
Upside: +61.14%
Maintains: Neutral
Price Target: $15$13
Current: $17.69
Upside: -26.51%
Maintains: Neutral
Price Target: $20$23
Current: $58.17
Upside: -60.46%
Initiates: Buy
Price Target: $50
Current: $7.38
Upside: +577.51%
Maintains: Buy
Price Target: $40$52
Current: $61.95
Upside: -16.06%
Upgrades: Buy
Price Target: $47$60
Current: $24.50
Upside: +144.90%
Maintains: Neutral
Price Target: $13$18
Current: $7.37
Upside: +144.23%
Initiates: Buy
Price Target: $17
Current: $7.79
Upside: +118.23%
Initiates: Outperform
Price Target: n/a
Current: $1.79
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $5.11
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $5.25
Upside: -